News
Latest news related to non-animal research
-
20 November 2024ECHA investigates how to replace toxicity testing with fish, EU consultation on AI Act, Deep RNA sequencing to explore human neurology, and more
NEWS, REPORTS & POSITION STATEMENTS 1. QMUL leads project to revolutionise drug discovery with next-generation organ-chip technology Queen Mary University of London (QMUL) in collaboration with a consortium of leading pharmaceutical companies, organ-chip technology providers, and regulatory bodies, has secured […]
Read more -
14 November 2024Tackling AI challenges in drug discovery, How hearts-on-chips can save millions, Revolutionary high-speed 3D bioprinter and more
NEWS, REPORTS & POSITION STATEMENTS 1. VICT3R : New European project aims to reduce animal testing using AI Launched in September, the VICT3R project (Virtual Control animals 3R) will analyze historical data from pharmaceutical companies to create synthetic virtual animals using generative […]
Read more -
6 November 2024Brazilian Chemical Management Bill, Call for US Central NAMs Data Hub, Survey on Reviewer Requests for Animal Experiments in India, and more
NEWS, REPORTS & POSITION STATEMENTS 1. Brazilian Senate : A chemicals management bill to limit animal testing to a “last resort” Brazil’s Senate has approved a new chemical management bill that restricts animal testing to a “last resort” and requires development […]
Read more -
29 October 2024Validation of NAMs, Dutch government fund towards non-animal research, ANR call on AI, In silico toxicology training course and more
NEWS, REPORTS & POSITION STATEMENTS 1. Accelerating the adoption of NAMs in food safety through collaboration The European Food Safety Authority (EFSA) has made some progress in recognizing the potential of NAMs, incorporating them into certain updated guidance documents. Nevertheless, […]
Read more -
23 October 2024Precision oncology agenda in the EU, Digital twin technology in the US, MPS World Summit : Call for abstract, MPS in toxicity testing and more
NEWS, REPORTS & POSITION STATEMENTS 1. EFPIA : Advancing the precision oncology agenda in the EU Access to precision oncology is essential to ensure optimal and timely treatment of patients with cancer. However, challenges to access precision oncology highlight disparities across countries […]
Read more
